SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000891293-16-000135
Filing Date
2016-03-23
Accepted
2016-03-23 18:47:40
Documents
1
Period of Report
2016-03-21

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3284
  Complete submission text file 0000891293-16-000135.txt   4737
Mailing Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Issuer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3101 WESTERN AVENUE, SUITE 600 SEATTLE WA 98121
Business Address
Plunkett Matthew (Reporting) CIK: 0001557551 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-12465 | Film No.: 161525088